Compound Summary
Compound Name: | 			Buformin | 
Compound CID: | 			2468 | 
Synonyms: | 			Buformin 1-Butylbiguanide Buformine Butylbiguanide Butyldiguanide More... | 
Iupac Name: | 			2-butyl-1-(diaminomethylidene)guanidine | 
InChI: | 					InChI=1S/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11) | 
InChIKey: | 				XSEUMFJMFFMCIU-UHFFFAOYSA-N | 
Canonical Smiles: | 		CCCCN=C(N)N=C(N)N | 
Isomeric Smiles: | 			CCCCN=C(N)N=C(N)N | 
Molecular Weight: | 		157.22 | 
Molecular Formula: | 			C6H15N5 | 
Molecular Weight: | 		157.22 | 
Molecular Formula: | 			C6H15N5 | 
Hydrogen Bond Donor Count: | 			3 | 
Hydrogen Bond Acceptor Count: | 			1 | 
Rotatable Bond Count: | 			4 | 
Heavy Atom Count: | 					11 | 
Complexity: | 				156 | 
| Buformin | Buformin | 
|---|---|
Buformin | 			
1-Butylbiguanide | 
Buformine | 			
Butylbiguanide | 
Butyldiguanide | 			
Butformin | 
692-13-7 | 			
Butylbiguanidum | 
Glybigid | 			
1-Butyldiguanide | 
Adebit | 			
BIGUANIDE, 1-BUTYL- | 
W 37 | 			
Imidodicarbonimidic diamide, N-butyl- | 
Biforon | 			
Diabrin | 
Panformin | 			
Sindiatil | 
Andere | 			
UNII-W2115E9C7B | 
N-butylimidodicarbonimidic diamide | 			
DBV hydrochloride | 
H 224 | 			
Imidodicarbonimidicdiamide, N-butyl- | 
Butyl guanylguanidine | 			
DBV | 
CHEBI:3209 | 			
692-13-7 (free base) | 
Glybigidum | 			
Butylbiguanide hydrochloride | 
N-Butylbiguanide | 			
W2115E9C7B | 
NCGC00164533-01 | 			
NCGC00164533-02 | 
Buformine INN-French | 			
Buforminum INN-Latin | 
DSSTox_CID_26420 | 			
DSSTox_RID_81598 | 
Buformina INN-Spanish | 			
DSSTox_GSID_46420 | 
Buforminum | 			
Buformina | 
Buformin USAN:INN | 			
n-Butylbiguanidine | 
CAS-692-13-7 | 			
NSC113665 | 
SB 103 | 			
EINECS 211-726-4 | 
BRN 0607037 | 			
Butylbiguanid | 
N1-Butylbiguanide | 			
N,n-butylbiguanide | 
1-n-butylbiguanide | 			
2-butyl-1-(diaminomethylene)guanidine | 
2-butyl-1-(diaminomethylidene)guanidine | 			
Buformin (USAN/INN) | 
SCHEMBL27451 | 			
4-04-00-00582 (Beilstein Handbook Reference) | 
CHEMBL39736 | 			
DTXSID6046420 | 
SCHEMBL15762988 | 			
1-butyl-3-carbamimidoyl-guanidine | 
ALBB-023188 | 			
Biguanide, 1-butyl-, hydrochloride | 
HY-B2099 | 			
ZINC4097425 | 
Tox21_112164 | 			
N-Butyldicarbonimido/ic diamide/imido | 
SBB056560 | 			
STL484281 | 
AKOS003382834 | 			
AKOS006228752 | 
Tox21_112164_1 | 			
DB04830 | 
MCULE-5413481004 | 			
NCGC00186641-01 | 
2-butyl-1-(diaminomethylidene)-guanidine | 			
ST088005 | 
amino(butylamino)iminomethylcarboxamidine | 			
CS-0017529 | 
C07674 | 			
D00595 | 
96642-EP2287163A1 | 			
96642-EP2305678A1 | 
179391-EP2275108A1 | 			
Q715104 | 
SR-01000944701 | 			
((1E)-1-amino-2-azahex-1-enyl)aminocarboxamidine | 
Imidodicarbonimidic diamide, N-butyl-, hydrochloride | 			
SR-01000944701-1 | 
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rattus norvegicus | 687 | 737 | 7.3 | 1054 | 1112 | 5.5 | S | LIO | FEMALES | 21084729 | Active | ||
| Rattus norvegicus | 5 | mg | 687 | 737 | 7.3 | 1054 | 1113 | 5.5 | S | LIO | FEMALES | 14618027 | Active | 
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Rattus norvegicus | 7.3 | 5.5 | 2 | 2 |